Macrogenics Inc

MGNX NASDAQ Santé & Biotech États-Unis US5560991094
3.96 $
1.25 %

MacroGenics développe des anticorps monoclonaux pour le traitement des maladies cancéreuses et auto-immunes.

Performance & Momentum

6 Months 189.05 %
1 Year 160.53 %
3 Years 34.44 %
5 Years 81.91 %

Similar stocks to Macrogenics Inc

Anantys Community

Be the first to share your analysis on Macrogenics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases